PEGASYS
information and resources from the National Cancer Institute
NCI Thesaurus | PEGASYS
(Other name for: PEG-interferon alfa-2a)NCI Thesaurus | PEGASYS
(Other name for: PEG-interferon alfa-2a)
|
|
|
|
news articles
Hepatitis C Market: Plenty Of Potential, But Little Progress 01 Apr 2006
Investor's Business Daily (subscription) ...protein that fights infection. Pegylated Interferon is sold as Pegasys by Roche and PEG-Intron by Schering-Plough. It reduces the ...
Auction takes in $5,000 for PEGASYS Mar 20, 2006
Enid News & Eagle, The live, on-air auction brought in about $5,000 for PEGASYS, but staff members had not figured out the profit from the purchased items. ...
Live program with children’s author slated for PEGASYS Mar 17, 2006
Enid News & Eagle, The next in a series of live programs from Kennedy Center for Performing Arts, Prince William Network, airs Tuesday on PEGASYS. ...
PEGASYS, college eyeing a partnership for television elective Mar 1, 2006
Enid News & Eagle, Ed Vineyard, NOC vice president for the Enid campus, told the PEGASYS board Tuesday he and PEGASYS director Wendy Quarles have met with NOC officials in ...
PEGASYS kicking off year-long 20th anniversarycelebration Mar 9, 2006
Enid News & Eagle, PEGASYS will host all its usual events -- Video Summer Camp, High School Media Day and Videofest -- with some special events and emphasis on honoring ...
PEGASYS plans auction Mar 13, 2006
Enid News & Eagle, Auction proceeds will help PEGASYS with operational costs. ... The auction is a way for PEGASYS to raise money and become more self-sufficient. ...
Official secrets Mar 31, 2006
Tehelka (subscription), Pricey Patent: Roche has received the first product patent under the new patent regime for Pegasys, a Hepatitis c drug, which will be available at about $5,000 ...
Roche gets hepatitis drug (Pegasys) patent in India Mar 6, 2006
RxPG NEWS, Roche India Pvt Ltd, the Indian arm of Swiss drugmaker F. Hoffmann La Roche, Friday received a product patent for its new generation hepatitis therapy Pegasys. ...
Novartis Hepatitis B News Priced In -Sarasin Mar 27, 2006
newratings.com Hepatitis C, Sarasin says, pegging sales potential of the treatment at $350M. Notes GlaxoSmithkline's (GSK) Epivir and Roche's (RHHBY) Pegasys are competitors. ...
- Interim 12-Week Data Suggest At Least Comparable Antiviral ... Mar 14, 2006
PR Newswire (press release), ...data at the 1200-mcg dose administered every two weeks show a trend for greater antiviral activity for Albuferon, compared with Pegasys administered every 7 ...
Human Genome Sciences Announces Positive Interim Results of Phase ... Mar 14, 2006
PR Newswire (press release), ...- Interim 12-Week Data Suggest At Least Comparable Antiviral Activity Versus Pegasys, With Less Frequent Dosing - - Conference Call Today At 10 AM Eastern ...
Novartis Licenses Hep C Drug Mar 29, 2006
Red Herring, Roche makes a $1.38-billion combination treatment for the disease called Pegasys/Copegus. Schering-Plough makes Peg-Intron/Rebetol, worth $1.1 billion a year. ...
HCV Data Drop HGS’ Shares; ‘Not Slam-Dunk,’ Analyst Says Mar 14, 2006
BioWorld Online (subscription), ...albumin-interferon alpha 2b), given every other week, at 12 weeks worked as well as the standard of care, which is weekly Pegasys (pegylated interferon alfa-2a ...
Roche bags the first product patent in India Mar 3, 2006
Webindia123, ..."Pegasys is the result of more than a decade of Roche's pioneering research. This product patent approval marks a major landmark for Roche in India. ...
Healthcare: At a Glance - Roche Hepatitis Drug Thrust Onto Front ... Mar 3, 2006
International News Service, The NHS in England and Wales is now recommended to use Roche's Pegasys (peginterferon alfa-2a) for the initial treatment of adults with chronic hepatitis B (CHB ...
Roche bags 20 year patent for liver disease therapy Mar 3, 2006
Indian Express, Roche (Roche). The patent has gone to Pegasys, Roche’s therapy for Hepatitis-C, for twenty years starting May 15, 1997. Hepatitis ...
Human Genome Sciences Seen Partnering Hep C Drug In 2006 Mar 16, 2006
Forbes ...after the biotech firm reported mixed results for its experimental hepatitis C treatment, Albuferon, from a Phase IIb head-to-head trial with Roche's Pegasys. ...
Roche garners first local patent Mar 3, 2006
Daily News & Analysis, Roche, on Friday became the first pharmaceutical company in India to receive a product patent under the new patent regime for its biotech drug, Pegasys, a new ...
Roche receives product patent for hepatitis therapy Mar 3, 2006
Zee News, Delhi, Mar 03: Swiss drug maker F Hoffman la-Roche today said with product patent approval for its new generation therapy against Hepatitis C 'Pegasys', it has ...
Roche receives patent for therapy Mar 3, 2006
Economic Times, NEW DELHI: Swiss drug maker F Hoffman La-Roche said with product patent approval for its new generation therapy against hepatitis C 'Pegasys', it has become ...
Human Genome down after early data out Mar 14, 2006
BusinessWeek ...the study where hepatitis C patients had never received treatment, subjects were given either Albuferon with ribavirin, or Hoffman-LaRoche's Pegasys, over 12 ...
Human Genome's Trial Data Builds Confidence On Wall Street Mar 14, 2006
Forbes ...clients. Preliminary results of the Phase IIb head-to-head study of pitting Albuferon against Roche's Pegasys were mixed. Efficacy ...
Idenix Provides Update on Clinical Development of Valopicitabine ... Mar 23, 2006
PR Newswire (press release), ...treatment arms, all involving dosing regimens of valopicitabine, administered once-daily, in combination with pegylated interferon alfa-2a (Pegasys(R)) 180 ug ...
Roche Hepatitis B drug offers medicine-free hope Mar 8, 2006
Reuters ZURICH, March 8 (Reuters) - Roche Holding AG's (ROG.VX: Quote, Profile, Research) hepatitis B drug Pegasys offers the prospect of a medicine-free life to some ...
Human Genome hep. C data seen good but no home run Mar 14, 2006
Reuters ...results showed its drug demonstrated greater antiviral activity when compared with Roche Holding AG's (ROG.VX: Quote, Profile, Research) Pegasys in patients ...
Roche gets first product patent in India Mar 1, 2006
Financial Express, ...product patent in pharmaceuticals to Roche India Pvt Ltd, the Indian arm of Swiss drugmaker F Hoffmann La Roche, for its biotech drug Pegasys (Peinterferon apha ...
HGSI's Albuferon for hepatitis C advancing Mar 14, 2006
United Press International In a phase 2b trial in interferon alpha-naive patients, Albuferon showed a trend toward being comparable to Pegasys with less frequent dosing. ...
Human Genome Sciences: challenging the pegylated interferons Mar 15, 2006
Pharmaceutical Business Review ...through combination therapy consisting of pegylated interferon (pegIFN) and ribavirin (RBV), marketed by Roche and Schering-Plough as Pegasys/Copegus and ...
Experimental Hepatitis C Treatment Not Effective in Monthly Dose ... Mar 16, 2006
Kaiser network.org, ...weeks in combination with Ribavirin exhibited lower hepatitis C viral levels, compared with 66% of patients receiving 180 micrograms of Pegasys, a hepatitis C ...
Pharma Stocks Flex Some Muscle Mar 17, 2006
Forbes Preliminary results of the head-to-head study of Albuferon and Roche's Pegasys were mixed, with efficacy for Albuferon slightly higher at 14-day dosing but ...
Rockville-Based Human Genome Sciences Inc.'s Stock Pounded Mar 15, 2006
International News Service, The study of 458 patients compared use of Albuferon and Roche Holding AG's Pegasys, when combined separately with ribavirin, an older hepatitis- C drug.
Idenix Provides Update on Clinical Development of Valopicitabine ... Mar 24, 2006
PharmaLive.com (press release), ...was designed to evaluate three dosing regimens of valopicitabine, administered once-daily, in combination with pegylated interferon alfa-2a (Pegasys(R)) 180 ug ...
International Speakers Reveal Encouraging Results at AMAGE ... Feb 27, 2006
Al-Bawaba, The results showed that 47 % of these patients treated with the standard combination of 180 mcg Pegasys plus Ribavirin have undetectable amounts of the virus ...
Cebridge Cable transfer gets nod Mar 22, 2006
Enid News & Eagle, While they are asking about cox 29, why don't they ask about Cox 21 and get C-Span 2 back on? Is this a good thing or a bad thing for Pegasys? ...
Folks, Enid has God written all over it ... Mar 17, 2006
Enid News & Eagle, ...the Chisholm Trail Expo Center that I believe promises good Christian things to come, Gaslight Theatre, Cherokee Strip Conference Center, PEGASYS public access ...
Some of best are at Vance Mar 4, 2006
Enid News & Eagle, We commend Northern Oklahoma College Enid and PEGASYS officials for beginning talks about creating a television production class here. ...
New hope for liver disease Feb 25, 2006
AME Info, Patients with hepatitis C, a debilitating liver disease, now have a fighting change thanks to a new drug called Pegasys, Dr. Graham Foster, Professor of ...
Human Genome hep. C data seen good but no home run Mar 14, 2006
Reuters ...in combination with ribavirin showed a greater antiviral activity when compared with Roche Holding AG's(ROG.VX: Quote, Profile, Research) Pegasys, a standard ...
Take Your Pills, All Your Pills Mar 10, 2006
New York Times, Each month that Mr. Brocato took the drug, Pegasys, and its companion pill, ribavirin, meant $3,000 in sales — most of it paid by his insurance company. ...
County getting ready for storms Mar 13, 2006
Enid News & Eagle, ...stations for weather updates. “If Enid is in a tornado warning, we will interrupt on PEGASYS,� Honigsberg said. “We can also ...
Enid, area emergency groups release booklets to prepare residents ... Feb 28, 2006
Enid News & Eagle, In addition to local radio stations, Honigsberg said PEGASYS will have emergency information for the Enid cable system, when it is on, but there is no current ...
News Digest: Top Newspaper Headlines Mar 1, 2006
Business Standard, No other company will be allowed to launch a generic version of Roche's Pegasys in India, although there is no threat to drugs introduced prior to January 2005 ...
Human Genome Sciences Reports Positive Interim Results of Phase 2 ... Mar 14, 2006
PR Newswire (press release), ...issued today, HGS announced the interim results of a larger Phase 2b clinical trial of Albuferon in combination with ribavirin, versus Pegasys with ribavirin ...
Take Your Pills, All Your Pills Mar 11, 2006
Gadsden Times (subscription), Each month that Mr. Brocato took the drug, Pegasys, and its companion pill, ribavirin, meant $3,000 in sales most of it paid by his insurance company. ...
Human Genome Sciences to Sponsor Conference Call to Discuss ... Mar 14, 2006
Yahoo! News (press release) ...* The interim results of a Phase 2b clinical trial of Albuferon in combination with ribavirin, versus Pegasys with ribavirin, in treatment- naive patients with ...
Hepatitis C Treatment for People With Severe Mental Illness Feb 28, 2006
Psychosomatics (subscription) Fried M, Schiffman M, Reddy R, et al: Pegylated (40kDa) (PEGASYS) interferon alfa-2a in combination with ribavirin: efficacy and safety results from a phase III ...
Human Genome Sciences to Sponsor Conference Call to Discuss ... Mar 14, 2006
PR Newswire (press release), ...those press releases, HGS reported: * The interim results of a Phase 2b clinical trial of Albuferon in combination with ribavirin, versus Pegasys with ribavirin ...
PEGASYS is seeking nominations for board Dec 14, 2005
Enid News & Eagle, The PEGASYS board has 14 members, who represent the city of Enid, Northern Oklahoma College Enid, Northwestern Oklahoma State University-Enid, Autry Technology ...
Enid children invited to talk with Santa on PEGASYS Dec 13, 2005
Enid News & Eagle, Enid kids are invited to call in to PEGASYS Thursday to talk to Santa Claus. ... Santa has been appearing on the PEGASYS call-in show for about 10 years.
PEGASYS to air calls to Santa live from 7-8 pm on Thursday Dec 8, 2005
Enid News & Eagle, PEGASYS’ annual calls to Santa will air live 7 to 8 pm Thursday on Cox Cable Channel 11. Kids of all ages are welcome to call ...
PEGASYS seeks ways to diversify programming Nov 29, 2005
Enid News & Eagle, By Robert Barron Staff Writer. PEGASYS is looking for a way to increase the ethnic diversity of Enid's public access television station. ...
TODAY ON PHARMALIVE.COM Dec 14, 2005
PharmaLive.com (press release), In all three arms, valopicitabine is given in combination with pegylated interferon alfa-2a (Pegasys(R)) 180 µg with the initial dose of pegylated ...
Partial 24-Week Data Demonstrate Valopicitabine (NM283) Combined ... Dec 14, 2005
PR Newswire (press release), In all three arms, valopicitabine is given in combination with pegylated interferon alfa-2a (Pegasys(R)) 180 5g with the initial dose of pegylated interferon ...
Higher doses of pegylated interferon or ribavirin improve ... Dec 8, 2005
Aidsmap, ...trial, 950 previous non-responders to Viraferon-Peg plus ribavirin were randomly assigned to receive pegylated interferon-alpha-2a (Pegasys), either 180mcg ...
Therapy May Aid Hepatitis Non-Responders, Early Study Results ... Dec 1, 2005
Hepatitis Neighborhood, ..."At 12 weeks, the combination of valopicitabine plus Pegasys [peginterferon alfa-2a] produced a significant improvement in the suppression of hepatitis C virus ...
Livers Under Wrap: ASLD 2005 Nov 25, 2005
MedPage Today, A study of 901 patients treated with pegylated interferon alfa-2a (Pegasys), or with the Copegus combination, during phase III trials found that up to five ...
Message in balloon proves mysterious Nov 24, 2005
The Grand Rapids Press, Horman said the only other clue is that the note was written on a piece of paper from a note pad with the word "Pegasys" on it from what she believes is the ...
Three Rivers Pharmaceuticals Announces FDA Final Approval of ... Dec 5, 2005
PharmaLive.com (press release), Ph. These new dosage strengths represent the first significant advance in the treatment of HCV since the launch of Pegasys(R). Ribavirin ...
FYI for 11-20-05 The Enid News and Eagle Nov 19, 2005
Enid News & Eagle, Jim Nay was honored at the 2005 PEGASYS VideoFest with first-place awards for his video productions "Changing Places" and "A Fling at the Springs, Volume 1 ...
Nektar India launches R&D centre Dec 4, 2005
Sify, ...of the breakthrough products that used Nektar's drug delivery technologies, Gill said the company has worked on PEG-Inteferon Alpha-2A (Pegasys-Roche) and PEG ...
Early treatment of hepatitis C effective in HIV-positive patients Nov 29, 2005
Aidsmap, Two small studies presented in Dublin assessed the impact of hepatitis C treatment with peginterferon alfa-2a (Pegasys) with or without ribavirin (Copegus ...
Nektar India's R&D centre in Hyderabad Dec 4, 2005
Andhra Cafe, ...drug discovery involves applications in biology, engineering and chemistry.The company has worked on products like PEG-Inteferon Alpha-2A (Pegasys-Roche) and ...
Hepatitis C combination therapies in pill form move nearer Nov 18, 2005
Aidsmap, ...one of three doses (400 mg, ramped dosing from 400 to 800 mg, or 800 mg once daily) of valopicitabine plus pegylated interferon alpha-2a (Pegasys) 180 mcg/week ...
|
|
